X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Year-over-year net income growth rate
Latest
19.76%
↑ 107% vs avg
Percentile
P86
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
-267.50%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 19.76% |
| Q3 2025 | -15.83% |
| Q2 2025 | -9228.01% |
| Q1 2025 | 100.71% |
| Q4 2024 | -8.52% |
| Q3 2024 | -140.40% |
| Q2 2024 | 275.47% |
| Q1 2024 | -170.60% |
| Q4 2023 | -729.93% |
| Q3 2023 | 95.86% |
| Q2 2023 | -131.94% |
| Q1 2023 | 17.47% |
| Q4 2022 | -34.83% |
| Q3 2022 | -1.76% |
| Q2 2022 | 3.43% |
| Q1 2022 | 27.29% |
| Q4 2021 | -49.72% |
| Q3 2021 | -2.73% |
| Q2 2021 | -5.15% |
| Q1 2021 | -1.50% |
| Q4 2020 | -5.45% |
| Q3 2020 | -15.22% |
| Q2 2020 | -35.97% |
| Q1 2020 | -2.78% |
| Q4 2019 | 38.82% |
| Q3 2019 | -32.36% |
| Q2 2019 | -23.08% |
| Q1 2019 | -16.19% |
| Q4 2018 | 14.15% |
| Q3 2018 | 10.16% |
| Q2 2018 | -14.14% |
| Q1 2018 | 4.98% |
| Q4 2017 | 3.56% |
| Q3 2017 | -103.33% |
| Q2 2017 | -5.94% |
| Q1 2017 | -1.20% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |